|Antibody has been listed as one of the Natural sciences good articles under the good article criteria. If you can improve it further, please do so. If it no longer meets these criteria, you can reassess it.|
|Current status: Good article|
|Antibody has been listed as a level-4 vital article in Science. If you can improve it, please do. This article has been rated as GA-Class.|
|This article is of interest to the following WikiProjects:|
|To-do list for Antibody:|
Some things I may tackle but feel free to help or comment!
Ciar 21:42, 20 May 2007 (UTC)
- 1 Untitled
- 2 From the article
- 3 Antibody function is a bit vague/poorly written
- 4 Difficult to Understand
- 5 Number of antibodies
- 6 Antibodies and immunoglobulins
- 7 Gamma vs. all
- 8 External Links to Antibody Research
- 9 IgM hexamer formation?
- 10 Sizes of antibody fragments
- 11 Why "Y" shaped
- 12 GA nomination
- 13 Redirection Issue
- 14 For safe-keeping
- 15 History
- 16 Use of brand name
- 17 Automatic addition of "class=GA"
- 18 Structure of antibodies
- 19 External link suggestion
- 20 Antibodies and immunoglobulins 2
- 21 Intrabody therapy - should it be in this article?
- 22 anti bodys
- 23 Structure prediction
- 24 How long until antibodies leave body?
- 25 Comments on the first paragraph of the article
- 26 Comment on the second paragraph of the article
- 27 Comment on the IgE section of the table
- 28 List of human proteins containing immunoglobulin domain
- 29 Antibodies are not Gammaglobulins
- 30 Need more on the attached sugars
- 31 Simplify lead
- 32 Assessment comment
- 33 External links modified
- 34 Section Antibody mimetic
- 35 Definition and Citation of Immature/Naive B cells and Application
The page history of this talk page prior to January 7 2005 was originally at Antibodies&Contributions which was felt to be an inappropriate title. The content had previously been merged with the Antibody article. Angela. 10:27, Jan 7, 2004 (UTC)
From the article
An anon deposited this in the article body:
- Some immunoglobulins are known to catalyze the formation of ozone from water, presumably to kill pathogenic agents in its vicinity. The catalytic mechanism for this process is unknown.
Does anyone know if this is correct? Google gives some high-ranking results, but I wonder if this isn't too tentative to make it into an encyclopedia. The first reference I can find is from 2003 (PMID 12967665). JFW | T@lk 11:17, 27 Sep 2004 (UTC)
I would have though that would be more about the "reactive oxygen" (superoxide etc) system in endolysosomes within the actual phagocytic cells, not directly from the Ig.--KX36 16:09, 14 February 2007 (UTC)
A science magazine article (http://www.sciencemag.org/cgi/reprint/298/5601/2195.pdf) says the ozone is produced from singlet molecular oxygen (that can be produced by neutrophils) and water. Not from water alone. Narayanese 16:19, 13 May 2007 (UTC)
Antibody function is a bit vague/poorly written
Would anybody object to me replacing it with something a whole lot clearer and more technical (Biochemistry perspective)?
I'm a tad busy, but will update in a couple of days?
--Hoju 12:13, 3 Nov 2004 (UTC)
There is also some inconsistency: The table says: "Functions mainly as an antigen receptor on B cells that have not been exposed to antigens. Its function is less defined than other isotypes."
But the texts reads, "Immature B cells, which have never been exposed to an antigen, are known as naïve B cells and express only the IgM isotype in a cell surface bound form."
Since B lymphocytes require antigen exposure to mature, I presume the table is correct, that naive B cells express fairly unspecific IgD; and only after maturing do they express IgM--? I ask because my immuno prof.s (I'm in med school) said IgD doesn't have a known function! Perhaps they should spend more time on Wikipedia...
Thanks for any clarification!
- You might also like to read Immunoglobulin D and the actual sources listed in this article. There are, to use scientific jargon, way the heck too many "stages" in B cell development, and the terms "immature" are "mature" refer to many different (and, depending on the writers, potentially overlapping) stages.
- The difference between "less defined" and "unknown" is not necessarily very great. WhatamIdoing (talk) 22:00, 29 October 2008 (UTC)
Difficult to Understand
Hello, as someone who has only an "average" understanding of chemistry and medicine, I found that this article was too technical. While I liked the indepth explanations, I simply could not understand the paragraphs included under "Definition", "Structure of the antibody" and "Isotypes". I hope I did not offend the author(s) of this article -- just keep it safe for the non Ph.D.s and MDs! :)
- Nobody said biology was simple. However, if something is not understandable, you can ask questions (be specific) and the authors or me at least will detail it further so the article will gradually become more readable. Anyway, if someone has a clear idea how to make this article more simple while at the same time keeping it accurate and all the facts included, just feel free to do it. --Eleassar777 23:52, 23 Feb 2005 (UTC)
- It is difficult to understand, more difficult than it needs to be. This is probably a function of cutting and pasting sentences from other resources like http://www.absoluteastronomy.com/encyclopedia/a/an/antibody.htm. There are also a few contradictions, for example "The monomer is composed of two heavy and two light chains" - an unusual use of the word monomer. When I have some time I'll clean this article up a bit.
- You are welcome to do so and thank you for having come here. Yes, perhaps this is an unusual use of the word monomer, however it is generally used in such a context. The other thing I wish to point out is that all the resources I used were offline resources, that are stated below, and some text (from the page you give) was written before I came here.
- Also, please use your signature. You create it with three tildes ~~~). Four tildes ~~~~ gives also the time and date you came here. Thanks. --Eleassar777 09:08, 24 Feb 2005 (UTC)
The immune system is a fascinating subject, but IMHO - this article is way too complicated for an encyclopedia. Also, it doesn't seem to link up with other parts of the immune system (unless it's buried and I missed it...) I remember understanding these processes backwards and forwards in college - but when I read this - I'm like, huh? Did something change in the last 3 years? I know there were some advances but this is really hard to absorb. I'd edit it myself but it's over my head at the moment. The immune system can be made much more easy to understand... like any subject. Even nuclear physics can be explained simply...and that involves math!
Number of antibodies
Is there information on how many different antibody molecules humans and other mammals (or even other animals) can express. I've got a text book where it says that mammals can produce 10^6 to 10^8 different antibodies. --EnSamulili 16:24, 11 May 2005 (UTC)
- Not very precise, uh? VDJ recombination produces a very large number, but I would avoid "mammals can produce 10^6 to 10^8 different antibodies". I would say: "Estimates differ on the number of possible antibodies that a mammal can produce. Some maintain it is 1,000,000, while others think it may be 100 times as much". JFW | T@lk 20:01, 11 May 2005 (UTC)
- Reasonable accurate figures can be calculated, and come out to about 10^16 possible antibodies in total. However the average human has about 10^12 B-cells, so this is the limit of individual antibody production. There is enough information on this to form a section on how antibodies generate diversity. I'll probably get round to this at some point --|Spaully 12:21, 1 February 2006 (UTC)
- There was a proof in one of my lectures that the VDJC recombination system can form ">10^8 different hypervariable regious (CDR's)". Some clever chap has worked out that that's a bigger number than the possible number of epitopes.
- Light chain has 1C, 35V, 5J; 3 different ways V and J join, 2 different light chains; makes 1050 combinations.
- Heavy chain has 1C, 45V, 6J, 20D, 3 different ways V and D join, 3 different ways D and J join; makes 48600 combinations.
- Now here's the dodgey bit. Making the assumption that all light chains can pair with all heavy chains, which isn't true, there's 51,030,000 combinations. Affinity maturation (somatic mutation) is estimated to roughly double this value to 10^8.
- I don't know how you got values of 10^16 antibodies and 10^12 B cells.--KX36 17:06, 14 February 2007 (UTC)
Antibodies and immunoglobulins
Are there any antibodies that are not immunoglobulins? --Eleassar777 12:41, 18 May 2005 (UTC)
- Antibody and Immunoglobulin are synonyms, they are literally the same thing. Philmcl 11:58, July 11 2006 (EST)
According to Stedman's Medical Dictionary vol 27 (immunoglobulin), there are some pathologically-produced immunoglobulins that do not function as antibodies, but I'm not sure how significant this fact is. Drangscleaner 18:23, 17 July 2006 (UTC)
- Very interesting. For reference, here's the link: 1528225, Stedman's Online Medical Dictionary at Lippincott Williams and Wilkins. And here's the key sentence: "Antibodies are Ig's, and all Ig's probably function as antibodies. However, Ig refers not only to the usual antibodies, but also to a great number of pathological proteins classified as myeloma proteins, which appear in multiple myeloma along with Bence Jones proteins, myeloma globulins, and Ig fragments." --Arcadian 18:57, 17 July 2006 (UTC)
Don't worry - all Ig's ("immunoglobulins") are antibodies and vice versa. All are produced by B-cells. --GeHa 21:42, 21 July 2006 (GMT)
Immunoglobulins are also produced by Plasma Cells (which in turn are the progeny of activated B-cells). I recently read a textbook (Basic Immunology, Abbas et al) that stated that more than half of the antibody present in the human body are produced by plasma cells. However, the experts seem to disagree on this point. Andbir (talk) 09:50, 20 May 2008 (UTC)
- Ahhh, but as you say, plasma cells are still B cells that have become huge due to their large scale production of antibody - they need all the space to make and process the protein! As for the confusion over Ig's above, immunoglobulin was a name given to describe an antibody when it was first characterized many years ago (based on its biochemical properties). Other proteins can be referred to Ig-like proteins or immunoglobulin superfamily (IgSF) proteins, since the have the same structural features (Ig-domains) as antibodies (the first known Igs), but they are not true "immunoglobulins" stricto senso. These other IgSF proteins are produced by cells other than B cells. ~ Ciar ~ (Talk to me!) 15:36, 20 May 2008 (UTC)
Some cancers are derived from B-cells ("myeloma"), and as these cells expand far beyond the usual for a normal B-cell (as cancers do), these may produce the one Ig that B-cell coded for in immense amounts. Normally, any individual Ig is only produced in large amounts when it has particular relevance - say, an anti-viral antibody during an active infection. However, as the continued growth of the B-cell "gone wild" is not being being driven by a productive immune response, the massive amounts of the immunoglobulin it is pouring out may or may not be binding anything known/useful. Perhaps this lead to the statement you quoted above. Antibodies reacting to self proteins are called autoantibodies and are thought to be driving certain diseases (Multiple sclerosis, rheumatoid arthritis, lupus...). These contribute to disease activity and are thus considered pathogenic/harmful. The immunoglobulins produced by the myelomas referred to here probably don't do anything harmful in their own right, but are secundary to the actual problem (i.e. cancer). Thus, they should not be considered pathological in the sense that they cause disease - they are merely symptoms of the underlying disease --GeHa 21:42, 21 July 2006 (GMT)
The immunoglobulins produced by myelomas are very harmful for the patient mainly causing serious damage to the kidneys leading to renal insufficiency in late stages. Kischel 23:07, 22 September 2007 (UTC)
- "Antibody" is a functional definition, something that binds antigens. "immunoglobulin" is a structural one. It could probably be said that T-cell receptors and MHC's are antibodies and although they contain immunoglobulin domains (as do many proteins), are not themselves immunoglobulins. I would also agree that an immunoglobulin without activity on an antigen is not an antibody--KX36 17:21, 14 February 2007 (UTC)
T-cell receptors and MHC's do interact with peptides while antibodies interact with molecular structures which are considerably larger. Antibodies also belong to a different section of the immune system with its own effector mechanisms. I would therefore strongly suggest not to use the term antibody for T-cell receptors or MHC molecules. Kischel 23:07, 22 September 2007 (UTC)
Gamma vs. all
External Links to Antibody Research
Antibody Sources, Suppliers, and Protocols] Suppliers of Custom Antibodies, and Antibodies by Field. Protocols for Western Blotting, Immunoprecipitationm and Antibody Microarrays.
Collected resource for antibody protocols]
IgM hexamer formation?
Does IgM ever adopt the hexemeric form under normal, non-disease process conditions? In know it can occur in some lymphomas, but thought the pentemer form was by far the most common. MarcoTolo 03:55, 4 February 2006 (UTC)
- IgM can only form hexamers without a J chain. Janeway ('05) describes the formation as 'occasional'. Will edit. Tricky 15:35, 10 March 2006 (UTC)
Sizes of antibody fragments
the picture's caption says "An antibody digested by papain yields two fragments, two 50 kDa Fab fragments and one 50kDa Fc fragment."
This is only true for certain Ig's. IgE and IgM have epsilon and mu heavy chains which have 5 domains, not 4; and as such, would have 75kDa Fc fragments. Also "two fragments; 2 Fab and a Fc" would be 3 fragments or 2 different fragments. Also, if you're saying the exact number of fragments for an antibody (rather than the number of different fragments), whether it's a monomer, dimer or pentamer would make a difference. I suggest this is rewritten.--KX36 17:12, 14 February 2007 (UTC)
Why "Y" shaped
Just quick question - why are antibodies "Y" shaped. From a layman's perspective, it seems to me that only one half of the Y is need for an antibody to work.
That is, it seems to me that only one receptor on one of the arms is needed to binding to the antigen.
Does two arms result in a simple doubling the number of binding sites, so as to double the number of "capture site" per molecule, or is there something more subtle to it all?
Thanks -- Quantockgoblin 17:11, 16 March 2007 (UTC)
- There's two quick answers, which I'm unclear how pertinent they'd be to the article, since they're essentially teleologic.
- 1) Binding of bivalent immunoglobulins of multiple epitope specificities allows for the formation of immune complexes
- 2) Activation of Fc receptors on effector cells (B cells, macrophages, etc.) may require cross-linking Jbarin 00:42, 7 May 2007 (UTC)
-> A third comment should be added to the question: Working with single-chain antibodies – a form of antibodies modified by biotechnological means, which possess only one binding domain - one does observe a significant reduction in the strength of binding of the single-chain antibody to its antigen ias compared with the original antibody having two binding sites - This observation strongly suggests that the two binding sites are also needed to improve the strength of binding. Kischel 22:45, 22 September 2007 (UTC)
H'mmm, I'm thinking this article is a little bit weak on the refs. I'll try and add some in when I can....anyone else able to help push this up to standard?? Thanks, Ciar 23:46, 30 March 2007 (UTC)
- I'd be happy to help out, let me know if you need anything special. First on my list will be to find some GOOD external links, hopefully to discourage some of the spamming.--DO11.10 00:00, 31 March 2007 (UTC)
As far as references go, this article is pretty good, for GA standard. I don't know how much you've done since 31 March, but it seems to be up to scratch. The only thing I am a little concerned about is the use of jargon in this article, however, as most of the jargon is blue-linked, that is OK for GA. The structure is consistent and well ordered. The lead section, while a little complex, does provide a suitable overview for the article.
As for stability, I can see there have been a lot of vandalism on this page in the past few hours, but otherwise the page is pretty stable, so I'm happy with that. Obviously, some school somewhere is using Wikipedia as a resource.
- It is reasonably well written.
- a (prose): b (MoS):
- It is factually accurate and verifiable.
- a (references): b (citations to reliable sources): c (OR):
- It is broad in its coverage.
- a (major aspects): b (focused):
- It follows the neutral point of view policy.
- a (fair representation): b (all significant views):
- It is stable.
- It contains images, where possible, to illustrate the topic.
- a (tagged and captioned): b lack of images (does not in itself exclude GA): c (non-free images have fair use rationales):
- a Pass/Fail:
So, as you can see, I am happy to pass this article to GA. It contains a good amount of well-structured, reliably sourced information that would be useful to many users.
If you want to take this article further, I would recommend trying to cut down on the amount of jargon used in the article and using simpler prose, for example "similar" instead of "analogous", to make it easier to understand. Don't go overboard though. Also, the lead section could do with some restructuring, perhaps to find a more suitable place for that second paragraph.
I would strongly suggest you get a peer review of this article and try and get as many editors as you can to comment, so as you can see where to go from here, before making any major changes. Otherwise, well done! Smomo 14:44, 3 April 2007 (UTC)
By b&w I mean black and white. 188.8.131.52 00:38, 7 May 2007 (UTC)
Never mind. It doesn't seem to be doing it anymore 184.108.40.206 00:39, 7 May 2007 (UTC)
Just trying to tidy up article following peer review so going to add/remove/move around stuff trying to get a good overall "big picture". Not sure the info below adds useful info to the antibody article so took it out for now...but didn't want to completely delete is....gonna pop it here for now if someone prefers it goes back in!
In an experimental setting, enzymes can be used to cleave the antibody into Fc and Fab fragments.
The variable regions of the heavy and light chains can be fused together to form a single chain variable fragment (scFv), which is only half the size of the Fab fragment yet retains the original specificity of the parent immunoglobulin.
Enzyme Location of cleavage First fragment Second fragment papain at hinge region two Fab fragments Fc fragment pepsin below hinge region one F(ab')2 fragment Fc fragment
I've noticed that a lot of reviewers want to see history sections in articles when they are proposed for the higher levels (!) so I put together a little mish-mash of history that I could find out there. I can't seem to make it flow though...any good copy-editors want to have a go?? Ciar 05:13, 6 June 2007 (UTC) Ciar 21:27, 20 May 2007 (UTC)
- Done. TimVickers 15:57, 6 June 2007 (UTC)
Use of brand name
Although it might be a very German concept - I do find the use of the brand name RhoGAM in the section about the Rhesus blood group slightly biased and therefore infringing on the guideline of neutral point of view. A general term for anti-Rhesus immunoglobulins should be used and the single reference to only one brand either deleted or expanded with other brand names. Kischel 23:29, 22 September 2007 (UTC)
- I agree.....and fixed it (hopefully!) Ciar 07:21, 23 September 2007 (UTC)
Automatic addition of "class=GA"
A bot has added class=GA to the WikiProject banners on this page, as it's listed as a good article. If you see a mistake, please revert, and leave a note on the bot's talk page. Thanks, BOT Giggabot (talk) 04:43, 10 December 2007 (UTC)
Structure of antibodies
"Each antibody has two large heavy chains H and two small light chains L."
Dear writers, I would like to suggest a link to the article on antibody generation on openwetware. The article in question is a technical description of how a biologist would go about generating a new antibody. It may be of interest to the public to see how antibodies are not just a natural phenomena but also a technique in the lab. To researchers this would be an interesting link with a lot of added information. Please consider it. Best, --Jakob Suckale (talk) 14:03, 24 April 2008 (UTC)
Antibodies and immunoglobulins 2
In #Antibodies and immunoglobulins it was discussed whether all antibodies are immunoglobulins. What remains uncler to me, is if all multicellular species immunoglobulins as antibodies. Do all species in the kingdom Animalia use immunoglobulins and nothing else, in internal defence. Samulili (talk) 12:19, 7 August 2008 (UTC)
- We commonly do not describe it as 'antibody' if it is not immunoglobulin, even though it would belong to immunoglobulin super family, have selective bindig ability or contribute to host defence. This review (Marchalonis and Schluter. Scand. J. Immunol. 1990; 32: 13–20.) may help you understand. Thanks. --Y tambe (talk) 03:00, 8 August 2008 (UTC)
- At the beginning of article: Antibodies (also known as immunoglobulins, abbreviated Ig) are gamma globulin proteins that are found in blood or other bodily fluids of vertebrates. I thought gamma globulins were IgG only. 220.127.116.11 (talk) 23:32, 20 February 2009 (UTC)
- If you check the link under gamma globulin, you will see the definition of this type of protein. All antibodies are gamma globulins. Gamma globulins belong to a large family of proteins found in the serum of blood -- this family contains other types (e.g. alpha and beta) of globulins. The gamma labeling of globulins refers to the grouping given to members of this protein family, based on their size/property differences.
- IgG is a type of gamma globulin (or immunoglobulin) that contains a "gamma" type heavy chain -- the gamma in this case refers to the gene coding for the heavy chain and is not the same as the "gamma" in gamma globulins. In other words, under the long naming system, IgG could be called "gamma globulin gamma", whereas IgA could be called "gamma globulin alpha" and so on. Hope this helps! ~ Ciar ~ (Talk to me!) 00:27, 21 February 2009 (UTC)
- At the beginning of article: Antibodies (also known as immunoglobulins, abbreviated Ig) are gamma globulin proteins that are found in blood or other bodily fluids of vertebrates. I thought gamma globulins were IgG only. 18.104.22.168 (talk) 23:32, 20 February 2009 (UTC)
Intrabody therapy - should it be in this article?
Wandering if intrabody should be a redirect to this article - it seems an emerging term for intracellular antibody and used in the context intrabody therapy as in this following review article, amongst others. If so is intrabody therapy covered or in the scope of this article? LeeVJ (talk) 22:42, 21 September 2008 (UTC)
- Hi Lee, I think a sentence or two could be added about this in the disease therapy section of the antibody article, but a more detailed stand alone article could be made to cover this novel type of antibody/antibody fragment, and its applications to science and medicine, which could be linked to/from this article. With more than 100 papers about these things available on pubmed, I'm sure it would be considered notable enough!! Best, ~ Ciar ~ (Talk to me!) 23:13, 21 September 2008 (UTC)
- Sample antibodys sells for $99. Just notised myself. sample-size-antibodies. Jack007 (talk) 09:41, 12 September 2015 (UTC)
I moved the section structure prediction to follow medical applications and research applications, since the content makes more sense if those sections are read first. ~ Ciar ~ (Talk to me!) 23:28, 24 December 2008 (UTC)
How long until antibodies leave body?
I couldn't find the answer to this in the article, if you HIV, you have HIV antibodies, your cured of HIV, how long until HIV antibodies leave the body, if ever? (obviously it would be the same for any virus, right?) If the answer is in the article, can someone please tell me where? If not, can someone please tell me what happens in the above example, once you are cured? And the reason I want to know is because I'm researching HIV, and there seems to be no way to tell if someone is cured, regardless whether or not there is a cure, it seems while a protocol for diagnosis exists there is no protocol for determining a cure. And anyway, if the virus was no longer in someone previously infected (like in my above example) what would happen to the antibodies?Jason1170 (talk) 16:55, 11 February 2009 (UTC)
- Serum antibodies will decay slowly, but the memory cells that can produce them will remain indefinitely. In the case of HIV, see PMID 16791025, which basically says that once you have the virus it is impossible (with present treatments) to totally eradicate it from the body. This reservoir problem is reviewed in PMID 11818490 Tim Vickers (talk) 17:23, 11 February 2009 (UTC)
You guys are crazy. Anything living can be killed, including some virus. As you likely know with HIV, the tests they use to confirm someone is positive are antibody tests. However, they say it usually takes 2-3 months for the body to produce antibodies. So, does it work vise versa? Does it take 2-3 months for the antibodies to disappear if the virus is totally killed? What would you estimate? Do you think that you should put the simple information that you gave to answer my question in the article? I don't understand how someone can say you can't be confirmed cured by antibody tests since you are officially diagnosed by testing positive for antibodies. And Tim, it doesn't matter what treatments can do, these idiots with millions can't find a cure, then they should be establishing a protocol to determine if someone is cured - like do something they're capable of. Jason1170 (talk) 16:37, 12 February 2009 (UTC)
- Testing uses both antibodies and RT-PCR, which detects viral RNA. Since the virus integrates into the genome of its host cells, it becomes part of these cells - so it will remain in the body for as long as these cells and their descendants do. This is called a "viral reservoir". If you look at the first paper I linked to it contrasts HIV, which can't be cured, with hepatitis C. Treatment of HIV does not lead to loss of antibodies, while treatment of hepatitis C does remove the antibodies. This is since hepatitis is curable and AIDS is not. Tim Vickers (talk) 17:45, 12 February 2009 (UTC)
Comments on the first paragraph of the article
1. Since the isotype of antibodies is not only determined by the different heavy chains but also by the different light chains (see Isotype (immunology)) - IgG, IgA, IgM, IgE and IgD should rather be referred to as classes, this would require changes not only in the first paragraph but also in the rest of the article. For the sake of clarity this should be done though.
2. Both references for the first paragraph (references 1 and 2) concern VDJ recombination and genomic structure of immunoglobulin loci - they do not support and provide information about the structure of antibodies as described in the first paragraph. Although the information in the first paragraph is correct to my knowledge, other references need to be given to support it.
--Teddy73 15:17, 19 August 2009 (UTC)
Comment on the second paragraph of the article
"These epitopes bind with their antibody in a highly specific interaction, called induced fit, that allows antibodies to identify and bind only their unique antigen in the midst of the millions of different molecules that make up an organism."
Working in the field of antibodies I have never heard of the term "induced fit" in connection with binding of antibodies to antigens. "Immunobiology" (reference 3 of the article) - a standard textbook of immunology - mentions induced fit only in connection with the binding of T cell receptors to peptide MHC complexes as a not yet proven theory. There is no reference regarding induced fit in connection with antibodies. Is there any reference in other sources supporting induced fit in binding of antibodies? If not this statement should be deleted
--Teddy73 15:17, 19 August 2009 (UTC)
Comment on the IgE section of the table
"Binds to allergens and triggers histamine release from mast cells and basophils, and is involved in allergy. Also protects against parasitic worms."
"Binds to allergens" mixes up cause and effect. Antigens binding to IgE trigger physiologic reactions, which in some cases cause the symptoms of an allergic disorder...
"protects against parasitic worms" remains for the time being a theory, which still remains to be proven (see: ). It should be marked as such.
--Teddy73 15:33, 19 August 2009 (UTC) --Teddy73 15:37, 19 August 2009 (UTC)
List of human proteins containing immunoglobulin domain
1060P11.7; A1BG; ACAM; ADAMTSL1; ADAMTSL3; AGER; ALCAM; AMIGO1; AMIGO2; AXL; BCAM; BGP; BGPc; BOC; BSG; BTLA; C10orf72; C20orf102; CADM1; CADM3; CD200; CD22; CD276; CD33; CD4; CDON; CEACAM1; CEACAM16; CEACAM20; CEACAM21; CEACAM5; CEACAM6; CEACAM8; CHL1; CILP; CNTFR; CNTN1; CNTN2; CNTN3; CNTN4; CNTN5; CNTN6; CSF1R; DSCAM; DSCAML1; EMB; F11R; FAIM3; FCAR; FCER1A; FCGR1A; FCGR2A; FCGR2B; FCGR2C; FCGR3A; FCGR3B; FCRH1; FCRH3; FCRH4; FCRL1; FCRL2; FCRL3; FCRL4; FCRL5; FCRL6; FCRLA; FGFR1; FGFR2; FGFR3; FGFR4; FGFRL1; FLT1; FLT3; FLT4; FSTL4; FSTL5; GP6; GPA33; GPR116; GPR125; HEPACAM; HLA-DMA; HLA-DMB; HLA-DQB; HLA-DQB1; HMCN1; HNT; HSPG2; HYST2477; ICAM3; ICAM5; IGHA1; IGHD; IGHE; IGSF10; IGSF11; IGSF2; IGSF21; IGSF3; IGSF9; IL11RA; IL1R1; IL1R2; IL1RAPL1; IL1RAPL2; IL1RL1; IL1RL2; IL6R; JAM2; JAM3; KIR-123FM; KIR2DL1; KIR2DL2; KIR2DL3; KIR2DL4; KIR2DL5A; KIR2DL5B; KIR2DLX; KIR2DS1; KIR2DS2; KIR2DS3; KIR2DS4; KIR2DS5; KIR3DL1; KIR3DL2; KIR3DL3; KIR3DS1; KIT; L1CAM; LAG3; LILRA1; LILRA2; LILRA3; LILRA4; LILRA5; LILRA6; LILRB1; LILRB2; LILRB3; LILRB4; LILRB5; LILRP2; LOC253012; LRIG2; LRIT1; LRRC4; LSAMP; MAG; MALT1; MCAM; MDGA1; MDGA2; MERTK; MFAP3; MIR; MIR; MXRA5; MYBPC3; MYOM1; MYOM3; NCA; NCAM1; NCAM2; NEGR1; NEO1; NFASC; NOPE; NPHS1; NPTN; NRCAM; NRG1; NT; NTRK3; OBSCN; OBSL1; OPCML; PAPLN; PDGFRA; PDGFRB; PDGFRL; PECAM1; PRODH2; PSG1; PSG10; PSG11; PSG11s'; PSG2; PSG3; PSG4; PSG5; PSG6; PSG7; PSG8; PSG9; PTGFRN; PTK7; PTPRD; PTPRK; PTPRM; PTPRS; PTPsigma; PUNC; PVR; PVRL1; PVRL2; PVRL4; RAGE; SCN1B; SDK1; SDK2; SEMA3A; SEMA3B; SEMA3E; SEMA3F; SEMA3G; SEMA4D; SIGLEC1; SIGLEC10; SIGLEC11; SIGLEC12; SIGLEC14; SIGLEC6; SIGLEC7; SIGLEC8; SIRPG; THY1; TIE1; TMIGD1; TMIGD2; TTN; TYRO3; UNC5D; VCAM1; VSIG1; VSIG2; VSIG4; Biophys (talk) 03:37, 27 August 2009 (UTC)
Antibodies are not Gammaglobulins
In the body article it states at the top in the primary definition that "antibodies are gammaglobulins". This is an absolute statement, it is incorrect. Some Ig's are gamma globulins but others fration in electrophoresis to be alpha or beta globulins. Re-read the definition of a gamma globulin and what i say will become apparent. Although i dont have a refrence for this im sure one is out there.
- Hi, 114. This is a common point of confusion, and has already been addressed on this page. Take a look at this exchange from last year. – ClockworkSoul 14:21, 13 April 2010 (UTC)
Need more on the attached sugars
The Structure sections says some of the amino acids have attached sugar chains but does not give any details or explain the significance. Is it these sugars that allow the body to recognise the antibodies as foreign ? Are some of these sugars asialated (whatever that means) ?Rod57 (talk) 15:10, 15 June 2010 (UTC)
A concern has been raised here that this article is not as clear as it could be. Please note that the first paragraph in the lead needs to be kept dead simple so that anyone can understand it. Looking back to a previous version at the time it was promoted to good article status, the first paragraph is in my opinion significantly clearer. Would anyone object if I try to restore some of the language of the previous version of the lead? In addition, I suggest that some of the more detailed description concerning antibody structure that is currently in the first paragraph of the lead could be split out into a new paragraph. Boghog (talk) 11:05, 6 February 2011 (UTC)
- Since no one has commented, I was bold and went ahead and edited the lead so that it now hopefully clearer. Boghog (talk) 20:39, 10 February 2011 (UTC)
The comment(s) below were originally left at several discussions in past years, these subpages are now deprecated. The comments may be irrelevant or outdated; if so, please feel free to remove this section., and are posted here for posterity. Following
|high school/SAT biology content + general/public knowledge - changed rating from high to top - tameeria 15:07, 18 February 2007 (UTC)|
Last edited at 15:07, 18 February 2007 (UTC). Substituted at 08:00, 29 April 2016 (UTC)
Hello fellow Wikipedians,
I have just modified 18 external links on Antibody. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
- Corrected formatting/usage for http://www.virology.ws/2009/10/06/natural-antibody-protects-against-viral-infection/
- Corrected formatting/usage for http://www.elispot-analyzers.de/english/elisa-animation.html
- Corrected formatting/usage for http://www.elispot-analyzers.de/english/elispot-animation.html
- Corrected formatting/usage for http://www.clsjep.cz/odkazy/kbm0603-146.pdf
- Corrected formatting/usage for http://bloodjournal.hematologylibrary.org/cgi/content/full/96/1/9
- Corrected formatting/usage for http://pathmicro.med.sc.edu/ghaffar/immunization.htm
- Corrected formatting/usage for http://antibody.bath.ac.uk/abmod.html
- Corrected formatting/usage for http://arianna.bio.uniroma1.it/pigs/
- Corrected formatting/usage for http://antibody.graylab.jhu.edu
- Corrected formatting/usage for http://www3.interscience.wiley.com/cgi-bin/fulltext/119531625/PDFSTART
- Corrected formatting/usage for http://www.scripps.edu/newsandviews/e_20081110/sculpture.html
- Corrected formatting/usage for http://www.boingboing.net/2008/10/22/protein-sculpture-in.html
- Corrected formatting/usage for http://nobelprize.org/nobel_prizes/medicine/laureates/1901/behring-bio.html
- Corrected formatting/usage for http://www.jem.org/cgi/reprint/203/1/5.pdf
- Corrected formatting/usage for http://profiles.nlm.nih.gov/MM/Views/Exhibit/narrative/specificity.html
- Corrected formatting/usage for http://users.path.ox.ac.uk/~seminars/halelibrary/Paper%2018.pdf
- Added archive https://web.archive.org/web/20070403013202/http://www.path.cam.ac.uk:80/~mrc7/mikeimages.html to http://www.path.cam.ac.uk/~mrc7/mikeimages.html
- Added archive https://web.archive.org/web/20070405170923/http://users.path.ox.ac.uk:80/~scobbold/tig/new1/mabth.html to http://users.path.ox.ac.uk/~scobbold/tig/new1/mabth.html
When you have finished reviewing my changes, please set the checked parameter below to true or failed to let others know (documentation at
|checked=, on this template, to true or failed to let other editors know you reviewed the change. If you find any errors, please use the tools below to fix them or call an editor by setting
|needhelp= to your help request.
- If you found an error with any archives or the URLs themselves, you can fix them with this tool.
|needhelp=<your help request> on this template to request help from an experienced user. Please include details about your problem, to help other editors.
Section Antibody mimetic
In this section, I cannot parse the sentence "Nucleic acids and small molecules are sometimes considered antibody mimetics, but not artificial antibodies, antibody fragments and fusion proteins are composed from these" What does "these" refer to? Is every item listed after "not" to be regarded as being refer to by it, or is this supposed to be two sentences, with the second sentence starting with "Antibody fragments"? Having a full second sentence content attached to the first half with no clear conjunction makes the whole ambiguous. Could someone who knows what is being said, fix this? 22.214.171.124 (talk) 05:56, 22 January 2017 (UTC)
Definition and Citation of Immature/Naive B cells and Application
A few comments and clarifications:
1. A citation for the last sentence in paragraph 3 in the overview is needed, in which the article states, "The allergen-IgE-FcRε interaction mediates allergic signal transduction to induce conditions such as asthma." Induction of asthma is a complex and still not completely understood process, so I think a citation that demonstrates the connection between the antibody interaction and the pathways that lead to asthma or allergic response would be very valuable here. If the citation could also address the previous two sentences as well, that would be even better. I would suggest 
2. Under the Subsection Isotypes, in the second paragraph, the article states, "Immature B cells, which have never been exposed to an antigen, express only the IgM isotype in a cell surface bound form. The B lymphocyte, in this ready-to-respond form, is known as a "naive B lymphocyte"." As it reads, it seems to imply that naive B lymphocytes are also immature B cells, which is false. While immature B cells and naive B lymphocytes have not been exposed to antigens, naive B lymphocytes are mature B lymphocytes, as they have undergone positive selection. I would recommend rewording this so that it isn't as ambiguous and difficult to understand.